Covid-19: FDA advisory panel rejects widespread Pfizer booster shots

Top Stories

Reuters
Reuters

Washington - Many of the experts who voted no expressed concerns about the risk of myocarditis with a third dose to younger males.

By AFP

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Fri 17 Sep 2021, 11:49 PM

Last updated: Fri 17 Sep 2021, 11:55 PM

Leading US medical experts advising the Food and Drug Administration on Friday voted against recommending booster doses of Pfizer’s Covid-19 vaccine for people aged 16 and up.

Many of the experts who voted no expressed concerns about the risk of myocarditis with a third dose to younger males, but said they were inclined to approve it for older age groups, if they were asked.


More news from